Cargando…
Genomic insights into head and neck cancer
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and is frequently impervious to curative treatment efforts. Similar to other cancers associated with prolonged exposure to carcinogens, HNSCCs often have a high burden of mutations, contributing to substantial in...
Autores principales: | Beck, Tim N., Golemis, Erica A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638139/ https://www.ncbi.nlm.nih.gov/pubmed/29034103 http://dx.doi.org/10.1186/s41199-016-0003-z |
Ejemplares similares
-
Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC)
por: Deneka, Alexander Y., et al.
Publicado: (2019) -
Phospho-(T356)RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck
por: Beck, Tim N., et al.
Publicado: (2015) -
Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer
por: Deneka, Alexander Y., et al.
Publicado: (2020) -
Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment
por: Viegas, Cláudia, et al.
Publicado: (2022) -
Genomically personalized therapy in head and neck cancer
por: Aung, Kyaw L., et al.
Publicado: (2016)